All Posts

In this volatile and increasingly uncertain world, there has never been a better time to stress-test the intelligence capabilities of any organisation, irrespective of market sector and size. Most companies discovered their supply chain vulnerabilities the hard way — through disruption. The same pattern is now playing out with geopolitical risk. The window to get ahead of it is closing fast.

Health insurance has always been a margin-sensitive industry. In the past, carriers could often differentiate through value-added wellness programs, large-scale marketing campaigns, and expanded benefit offerings. While those elements still play a role, the market has fundamentally shifted. Today, the U.S. health insurance industry is increasingly defined by cost pressure and margin management, as carriers struggle to balance rising healthcare expenses against...

We recently marked Rare Disease Day, a vital moment for the community. For those impacted by rare pathologies, the journey is often defined by a grueling "diagnostic odyssey," complex symptom management, and the constant hurdle of managed care coverage. For many, cell and gene therapy (CGT) represents the ultimate beacon of hope—offering not just chronic disease management, but the potential for curative outcomes.